USPTO serial 88101296
ELEVIAN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- GULIANO, ROBERT N
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ELEVIAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Menlo Park, CA
Miami Beach, FL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John L. Slafsky
John L. Slafsky WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the treatment and prevention of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and disease and conditions associated with aging and diabetes; transdermal drug delivery patches sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and diseases and conditions associated with aging and diabetes; implantable subcutaneous or intramuscular drug delivery devices sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and diseases and conditions associated with aging and diabetes; medical devices, namely, implantable or external pumps sold with pharmaceutical preparations for the treatment of cardiovascular conditions, neurological conditions, musculoskeletal conditions, dermatological conditions, pulmonary conditions, metabolic conditions, and disease and conditions associated with aging and diabetes for delivering drugs | ACTIVE | — |
| 010 | drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; vacuum pumps for medical purposes; tubing for use with catheters; drug eluting coatings sold as an integral part of catheters | ACTIVE | — |
| 044 | pharmaceutical and medical diagnostic consultation services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Elevian, Inc.
- Other trademarks owned by Elevian, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named ELEVIAN
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 27, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 26, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 19, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 18, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 18, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 12, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 12, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 21, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 19, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 19, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 19, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 18, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 14, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 14, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 14, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 31, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 29, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 29, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 29, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 1, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 29, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 29, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 29, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 19, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 24, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 24, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 4, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 20, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 20, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 20, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 20, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 20, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 20, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 30, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 15, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 5, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 5, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 5, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 5, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 5, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 19, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 2, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 2, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 2, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Dec 13, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 10, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 4, 2018 | NWAP | NEW APPLICATION ENTERED | — |